Status:
COMPLETED
Evaluating Face-Recognition Technology in Syndrome Diagnosis
Lead Sponsor:
Manchester University NHS Foundation Trust
Collaborating Sponsors:
FDNA Inc.
Conditions:
Multiple Anomalies
Dysmorphic Features
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
Birth defects are relatively common, occurring in 1 in 40 live born babies. They can be single, or multiple. They may occur as part of multiple malformation syndromes, often in association with growth...
Detailed Description
Clinicians see over 2000 patients per year who have rare syndromes in Manchester NHS clinics. In the majority of these individuals the cause is unknown. Many will have a genetic cause, but knowing whi...
Eligibility Criteria
Inclusion
- \- Patients attending routine genetic clinic/paediatric clinic appointments for diagnosis of a multiple anomaly syndrome where distinctive facial features form part of their presenting pattern.
- OR:
- \- Biochemically or genetically confirmed diagnosis of inborn disorder of metabolism where no well described dysmorphic facial features are known to be associated with disorder
Exclusion
- Patients under 8 months of age where face-recognition technology has not been shown to be effective.
- Patients who decline clinical photography as part of standard care.
- Patients who do not wish to consent to participation in the study even though they consent to photos being taken for standard care.
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04709965
Start Date
January 30 2018
End Date
November 25 2020
Last Update
January 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M13 9WL